LISA STENVERS: Open Payments
NPI 1841265097 · FREMONT, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,318 in 88 payments from 23 companies in 2025. Trend: 2023 $1,012 · 2024 $819 · 2025 $1,318
Food & beverage: $1,318
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $219 |
| Novo Nordisk Inc | 11 | $173 |
| PFIZER INC. | 11 | $158 |
| Lilly USA, LLC | 10 | $114 |
| Otsuka America Pharmaceutical, Inc. | 6 | $107 |
| AstraZeneca Pharmaceuticals LP | 6 | $97 |
| Amgen Inc. | 5 | $85 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Ardelyx, Inc. | 2 | $29 |
Products named: VRAYLAR, REXULTI, Wegovy, EVENITY, MOUNJARO, Ozempic, NURTEC ODT, VYNDAMAX.
Industry payments across NE — which companies pay providers there.
